…n a number of successful start-up companies. These have included Pearl Therapeutics (NLV-I, exited in sale to Astra Zeneca, 2.5x multiple plus milestones), Relypsa (NLV-I,_ private initially, now public on NASDAQ: RLYP), Convergence/Calchan...
Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction
IMAGES-007-HOUSE_OVERSIGHT_024045.txt
p.1
View source release ↗